Pharmaron Beijing Co., Ltd. (300759.SZ)
CNY 22.06
(-0.68%)
CNY 22.06
(-0.68%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 3.88 Billion CNY | 0.87% |
| 2022 | 3.76 Billion CNY | 40.67% |
| 2021 | 2.67 Billion CNY | 39.27% |
| 2020 | 1.92 Billion CNY | 44.15% |
| 2019 | 1.33 Billion CNY | 41.25% |
| 2018 | 944.66 Million CNY | 25.79% |
| 2017 | 751.01 Million CNY | 58.44% |
| 2016 | 474.01 Million CNY | 52.71% |
| 2015 | 310.39 Million CNY | 56.49% |
| 2014 | 198.34 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 1.11 Billion CNY | 23.26% |
| 2024 Q1 | 842.49 Million CNY | -12.41% |
| 2024 Q2 | 904.8 Million CNY | 7.4% |
| 2023 FY | 3.8 Billion CNY | 0.87% |
| 2023 Q3 | 1.02 Billion CNY | -4.22% |
| 2023 Q2 | 1.07 Billion CNY | 10.17% |
| 2023 Q1 | 974.96 Million CNY | -8.65% |
| 2023 Q4 | 961.87 Million CNY | -6.51% |
| 2022 Q1 | 695.62 Million CNY | -6.04% |
| 2022 Q3 | 1.07 Billion CNY | 16.34% |
| 2022 Q4 | 1.06 Billion CNY | -1.03% |
| 2022 FY | 3.76 Billion CNY | 40.67% |
| 2022 Q2 | 927 Million CNY | 33.26% |
| 2021 Q3 | 745.56 Million CNY | 10.35% |
| 2021 Q4 | 740.37 Million CNY | -0.7% |
| 2021 Q1 | 517.31 Million CNY | -9.24% |
| 2021 FY | 2.67 Billion CNY | 39.27% |
| 2021 Q2 | 675.65 Million CNY | 30.61% |
| 2020 Q3 | 554.93 Million CNY | 16.19% |
| 2020 Q2 | 477.62 Million CNY | 48.81% |
| 2020 Q1 | 320.96 Million CNY | -28.99% |
| 2020 FY | 1.92 Billion CNY | 44.15% |
| 2020 Q4 | 570 Million CNY | 2.72% |
| 2019 Q4 | 452.01 Million CNY | 26.41% |
| 2019 Q3 | 357.57 Million CNY | 30.66% |
| 2019 Q2 | 273.66 Million CNY | 8.97% |
| 2019 Q1 | 251.13 Million CNY | -15.49% |
| 2019 FY | 1.33 Billion CNY | 41.25% |
| 2018 Q4 | 297.15 Million CNY | 17.82% |
| 2018 FY | 944.66 Million CNY | 25.79% |
| 2018 Q3 | 252.2 Million CNY | 35.54% |
| 2018 Q2 | 186.07 Million CNY | -5.03% |
| 2018 Q1 | 195.93 Million CNY | -4.1% |
| 2017 Q4 | 204.31 Million CNY | 0.0% |
| 2017 FY | 751.01 Million CNY | 58.44% |
| 2016 FY | 474.01 Million CNY | 52.71% |
| 2015 FY | 310.39 Million CNY | 56.49% |
| 2014 FY | 198.34 Million CNY | 0.0% |